Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 463
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04385550 | A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | ||
| NCT05800418 | Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers | ||
| NCT01878448 | A Phase II Study of Anlotinib in STS Patients | ||
| NCT06700395 | A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma | ||
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT05493995 | A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. | ||
| NCT07569757 | Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma | ||
| NCT05985187 | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. | ||
| NCT02072044 | Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy | ||
| NCT03777085 | Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL) | ||
| NCT03998085 | Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC | ||
| NCT04275050 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets | ||
| NCT06456138 | Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC | ||
| NCT05610202 | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects | ||
| NCT05154630 | Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT04202653 | Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) | ||
| NCT07601204 | Treatment of Recurrent/Metastatic Head and Neck Cancer | ||
| NCT06469879 | A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients | ||
| NCT05828953 | Anlotinib Capsules in the Treatment for IPF/PF-ILDs | ||
| NCT07633314 | A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease | ||
| NCT05982106 | To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects | ||
| NCT07043751 | A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors | ||
| NCT06388759 | TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients | ||
| NCT05866510 | Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer | ||
| NCT04344158 | A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) | ||
| NCT03019276 | A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics | ||
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer | ||
| NCT07663526 | Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi® | ||
| NCT03991975 | Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma | ||
| NCT04203719 | A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer | ||
| NCT06297655 | A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A | ||
| NCT03750916 | Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer | ||
| NCT05745363 | Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer | ||
| NCT06475599 | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer | ||
| NCT07538271 | A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer | ||
| NCT06429397 | Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma | ||
| NCT03527888 | Study of Anlotinib in Patients With Primary Malignant Bone Tumors | ||
| NCT01924195 | Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） | ||
| NCT05975645 | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | ||
| NCT05634473 | A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test | ||
| NCT01874873 | A Phase II Study of Anlotinib in MTC Patients | ||
| NCT03743129 | Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） | ||
| NCT07367529 | A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection | ||
| NCT06245941 | A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF) | ||
| NCT06448273 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects | ||
| NCT04325776 | A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis | ||
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | ||
| NCT06507891 | A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets | ||
| NCT06230588 | A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | ||
| NCT06202261 | A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer |
